|
|
|
Immune cells traveling in the bloodstream can abruptly stop at signs of trouble according to new research in the May issue of Nature Immunology. By responding to chemical signals deposited on blood vessel walls, immune cells rapidly deploy specialized attachment molecules that latch onto cells lining the blood vessel, allowing their exit into the damaged tissues.
Previously, exit from the bloodstream was thought to be a gradual process that required braking before exiting at the site of final immune cell arrest. Ronen Alon and colleagues dispel this notion by showing immune cells can immediately stop upon encountering immobilized chemokines ? which act as traffic signals for these cells. Chemokines trigger extension of surface adhesion molecules called LFA-1. The process of extending these molecules unveils a specialized region that acts as a grappling hook for receptors expressed on blood vessel cells. Importantly, it is the immobilized form of chemokine that mediates this signal. The new work explains how immune cells that act as first responders can quickly arrive at scenes of damage. Author contact: Ronen Alon (Weizmann Institute of Science, Rehovot, Israel) E-mail: ronen.alon@weizmann.ac.il Also available online. (C) Nature Immunology press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
|
|
A Window on Breast Cancer
Souped-Up T Cells
Making an Impact on Reproduction
Fighting Neuroblastoma
Neuronal Contribution to Risk of Multiple Sclerosis
Risk Variants for Intracranial Aneurysm
Duplicitous Role for Classic Cancer Molecule
Monkey Vaccine Fights Off AIDS
Engineered DNA 'Scissors' Show Promise
Cancer Genome Sequenced
The Promise of Personal Genomics
Widespread Alternative Splicing
more news ...
|